Adamchak Mark 4

What Happened

• Mark Adamchak, Principal Accounting Officer of Bionano Genomics, reported that 7 shares of common stock were withheld by the company on June 3, 2026 to satisfy tax-withholding obligations related to RSUs that vested that day. The shares were valued at $1.30 each, totaling $9.
• This was a tax-withholding/cashless settlement of vested restricted stock units (not an open-market sale or purchase).

Key Details

• Transaction date and price: June 3, 2026 — 7 shares withheld at $1.30 per share (total $9).
• Transaction code: F (withholding to satisfy tax obligations).
• Footnote: The shares were withheld in connection with RSUs granted on June 3, 2024 and vesting on June 3, 2026.
• Shares owned after transaction: Not reported in the provided filing details.
• Filing timeliness: Report filed same day (no late filing indicated).

Context

• This is a routine tax-withholding event when RSUs vest; the company retained shares instead of issuing cash or selling shares on the open market. It does not signal a discretionary sale by the insider and typically has no direct implication about insider sentiment.